Placebo to FTC TDF

2 trials

Sponsors

MSD Pty Ltd

Conditions

HIV/AIDS

Phase 3

MK8527-010: MK-8527 as HIV-1 PrEP in Women

Active, not recruitingPACTR202509662689795

MSD Pty LtdHIV/AIDS

Start: 2025-09-27Target: 4580Updated: 2026-09-14

MK8527-011: MK-8527 as HIV-1 PrEP

Active, not recruitingPACTR202509563273736

MSD Pty LtdHIV/AIDS

Start: 2025-09-01Target: 500Updated: 2026-09-14